Quantcast
Channel: Latest Crohn's Disease News on BioPortfolio
Browsing all 2985 articles
Browse latest View live
↧

Deciphera Pharmaceuticals LLC Pharmaceuticals Healthcare Deals and Alliances...

SummaryDeciphera Pharmaceuticals LLC Deciphera Pharmaceuticals is a drug research and development company that develops designs and commercializes kinase inhibiting drugs for treating immunological...

View Article


Global Inflammatory Bowel Diseases IBD Drug Market Forecast 20172027

LONDON April 3 2017 PRNewswire Aminosalicylates Antibiotics Corticosteroids Immunomodulators Biologics Crohn's Disease Ulcerative Colitis The global inflammatory bowel diseases IBD drug market is...

View Article


New Revelations for Redness Rosacea Awareness Month Highlights Warning Signs...

The National Rosacea Society has designated April as Rosacea Awareness Month to alert the public to the early warning signs of this chronic and conspicuous facial condition now estimated to affect more...

View Article

RedHill Biopharma Receives FDA Orphan Drug Designation for YELIVAÂ for the...

Orphan Drug designation allows RedHill to benefit from various development incentives to develop YELIVAÂ ABC294640 for cholangiocarcinoma as well as a sevenyear marketing exclusivity period for the...

View Article

A Safe Place to Talk about Crohn's

Anxiety and embarrassment are a vicious circle for people with Crohn's disease. The psychological and emotional effects of this complex and often unrecognized condition not only dominate patient' lives...

View Article


Galapagos Launches 3 New Trials to Expand into Profitable Indications

Galapagos has announced three new Phase II trials to expand the indications of filgotinib which the biotech develops in partnership with Gilead. Galapagos&8217; lead candidate filgotinib is in...

View Article

Finch Therapeutics and Takeda Announce Global Collaboration to Develop...

The collaboration agreement grants Takeda an exclusive worldwide license to FIN524 a synthetic microbiome therapy for IBD and rights to followon products in IBD Finch Therapeutics a privately held...

View Article

RedHill Biopharma Announces Exclusive U.S. License from Entera Health for...

RedHill expects to initiate U.S. promotion of its two commerciallyavailable gastrointestinal specialty products DonnatalÂ1 and EnteraGamÂ2 in mid2017Under the terms of the agreement RedHill will pay...

View Article


Grant to support research aimed at benefitting patients with IBD

University of California Riverside Inflammatory bowel disease is a chronic inflammatory disease of the intestine that includes Crohn's disease and ulcerative colitis. A protective protein that plays a...

View Article


A Quick Primer on Crohns Disease

Crohns disease is an idiopathic chronic inflammatory process that can affect any part of the gastrointestinal GI tract from the mouth to the anus. Individuals with Crohns disease often experience...

View Article

UC Riverside professor receives grant to explore therapeutic target for...

Inflammatory bowel disease IBD is a chronic inflammatory disease of the intestine that includes Crohn's disease and ulcerative colitis. A protective protein that plays a key role in this disease is...

View Article

Enzon Pharmaceuticals Inc ENZN Pharmaceuticals Healthcare Deals and Alliances...

SummaryEnzon Pharmaceuticals Inc Enzon is a biotechnology company which researches and develops therapeutics for patients with high unmet medical needs. The company's royalty products include PegIntron...

View Article

Celltrion Inc 068270 Pharmaceuticals Healthcare Deals and Alliances Profile...

SummaryCelltrion Inc Celltrion is a biopharmaceutical company that focuses on research development and manufacture of biosimilars and novel biopharmaceuticals. The company offers monoclonal antibodies...

View Article


Diplomat Pharmacy Inc DPLO Pharmaceuticals Healthcare Deals and Alliances...

SummaryDiplomat Pharmacy Inc Diplomat Pharmacy is a healthcare company that provides medication management and clinical services. The pharmacy offers personalized medication therapies to people with...

View Article

Soligenix Inc SNGX Pharmaceuticals Healthcare Deals and Alliances Profile...

SummarySoligenix Inc Soligenix is a latestage biopharmaceutical company which focuses on the development of products for the treatment of serious inflammatory diseases and biodefense counter measures....

View Article


TaiwanJ Pharmaceuticals Co Ltd 6549 Pharmaceuticals Healthcare Deals and...

SummaryTaiwanJ Pharmaceuticals Co Ltd TaiwanJ is a pharmaceutical company that develops and commercialize firstinclass small molecules as TLR4 tolllike receptor 4 antagonists. TLR4 is a transmembrane...

View Article

Takeda Enters into Strategic Collaboration with NuBiyota for Microbiome...

Takeda Pharmaceutical Company Limited TOKYO4502 today announced a strategic collaboration with NuBiyota LLC for the development of Microbial Ecosystem Therapeutic products for gastroenterology GI...

View Article


AbbVie Inc ABBV Pharmaceuticals Healthcare Deals and Alliances Profile...

SummaryAbbVie Inc AbbVie is a researchbased biopharmaceutical company that carries out the research development manufacture and commercialization of advanced therapies to treat complex and serious...

View Article

Crohn's & Colitis Foundation & American Gastroenterological Association...

NEW YORK April 11 2017 PRNewswireUSNewswire The Crohn's & Colitis Foundation the Foundation and the American Gastroenterological Association AGA in collaboration with Pfizer Inc. announced...

View Article

Aevi Genomic Medicine to Present Updated Results from SAGA Trial of AEVI001...

PHILADELPHIA PA Marketwired 041217 Aevi Genomic Medicine Inc. NASDAQ GNMX the Company today announced that results identifying a genomic subset of responders from the SAGA trial of AEVI001 will be...

View Article
Browsing all 2985 articles
Browse latest View live